Document is current
Any future updates will be listed below
-
Authors
Mao, Shaoshuai https://orcid.org/0009-0001-8130-1985
Peng, Wenbo
Feng, Zhengyan
Chen, Yang
Sun, Jing
Chen, Haiting
Wang, Pengcheng
Huang, Pinzheng https://orcid.org/0009-0003-5946-4053
Zhao, Junzheng
Wu, Leilei
Wang, Yifan
Liu, Junjian
Luo, Hao
Zang, Ying
Yang, Changqing
Qiao, Xue
Lu, Zhiwei
Wu, Hongjun
Chen, Mingjie
Sun, Di
Xie, Jun
Sun, Yidi https://orcid.org/0000-0002-4191-2917
Zhou, Changyang https://orcid.org/0000-0002-3012-1001
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 1 September 2025
First Online: 1 October 2025
Competing interests
: S.M., W.P., Z.F., Y.C., J.S., P.W., P.H., J.Z., L.W., Y.W., J.L., H.L., Y.Z., C.Y., X.Q., Z.L., H.W., M.C. and D.S. are employees of Epigenic Therapeutics. C.Z. and Y.S. are scientific co-founders of Epigenic Therapeutics. The study was supported by grants from Epigenic Therapeutics and the Institute of Neuroscience. The authors also declare patent applications related to various aspects of epigenetic editors and delivery methods.
